logo

For the Inventor, By the Inventor

Rome, Italy

Maria Ornella Tinti

This inventor holds 81 USPTO granted patents, plus 3 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry (CPC class 514547). Top assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., Istituto Nazionale Per Lo Studio E La Cura Dei Tumori, Instituto Nazionale Per Lo Studio E La Cura Dei Tumori. Active years: 1980-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Ornella Tinti. Retrieved from https://idiyas.com/inventor/maria-ornella-tinti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 81

% Patents Active = 74.1



Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 252(Granted Patents)

Forward Citations (Not Self Cited) = 227(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • 00182 Rome, IT (1999)
  • Roma, IT (2002 - 2005)
  • Pomezia, IT (2008 - 2010)
  • Rome, IT (1980 - 2012)

Company Filing History:

goldMedal74 out of 343 
 
Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.
 patents
silverMedal3 out of 14 
 
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori
 patents
bronzeMedal2 out of 3 
 
Instituto Nazionale Per Lo Studio E La Cura Dei Tumori
 patents
4. 2 out of 6 
 
Sigma-Tau
 patents
5. 1 out of 1 
 
501 Sigma Tau Industrie Farmaceutiche Riunite S.p.a.
 patent
6. 1 out of 3 
 
Sigma-Tau Farmaceutiche Riunite, S.p.a.
 patents
7. 1 out of 20 
 
Sigma-Tau Healthscience S.p.a.
 patents
8. 2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1980-2012

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Camptothecin
L-Carnitine
Antitumor Agents
Cationic Lipids
Phosphodiesterase IV
Antipsychotic Activity
Immunomodulators
Chemical Synthesis
Solid Compositions
Reversible Inhibitors
Diabetes Treatment
Oral Administration
81 patents (USPTO):Explore Patents
1. 8124769 - Stereoselective process and crystalline forms of a camptothecin (2012-02-28),
2. 8101758 - Stereoselective process and crystalline forms of a camptothecin (2012-01-24),
3. 7858820 - Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride (2010-12-28),
4. 7799921 - Stereoselective process and crystalline forms of a camptothecin (2010-09-21),
5. 7713956 - Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity (2010-05-11),
6. 7705012 - Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents (2010-04-27),
7. RE41226 - Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase (2010-04-12),
8. 7629003 - Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds (2009-12-08),
9. 7612081 - 7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups (2009-11-03),
10. 7589099 - 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists (2009-09-15),
11. 7585519 - Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds (2009-09-08),
12. 7572778 - Fluorocombretastatin and derivatives thereof (2009-08-11),
13. RE40861 - Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase (2009-07-20),
14. 7498340 - Esters in position 20 of camptothecins (2009-03-03),
15. 7452900 - Esters in position 20 of camptothecins (2008-11-18),

Title: Maria Ornella Tinti - Innovative Inventor from Rome

Introduction: Maria Ornella Tinti is a pioneering inventor hailing from the historic city of Rome, Italy. With a passion for creativity and problem-solving, she has made significant contributions to the field of innovation.

Latest Patents: Maria Ornella Tinti holds several patents in various industries, including technology, healthcare, and sustainable energy. Her innovative ideas have led to groundbreaking solutions that have improved the lives of many.

Career Highlights: Throughout her career, Maria Ornella Tinti has been recognized for her ingenuity and forward-thinking approach. She has received numerous awards for her inventions and has been invited to speak at prestigious conferences around the world.

Collaborations: Maria Ornella Tinti has collaborated with leading companies, research institutions, and universities to bring her ideas to life. Her ability to work with diverse teams and leverage collective expertise has been instrumental in the success of her projects.

Conclusion: Maria Ornella Tinti's dedication to innovation and her relentless pursuit of new ideas continue to inspire the next generation of inventors. Her impact on the world of inventions is truly remarkable, and her legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…